Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BEKE-W
02423
5
TRIP.COM-S
09961
US Stock MarketDetailed Quotes
Bright Minds Biosciences (DRUG)
- 81.500
- +1.000+1.24%
Trading Dec 8 11:44 ET
577.72MMarket Cap-82.24P/E (TTM)
81.500High75.070Low85.68KVolume80.630Open80.500Prev Close6.82MTurnover3.31%Turnover RatioLossP/E (Static)7.09MShares82.00052wk High15.41P/B210.90MFloat Cap23.17552wk Low--Dividend TTM2.59MShs Float82.000Historical High--Div Yield TTM7.99%Range %0.930Historical Low79.574Avg Price1Lot Size
Bright Minds Biosciences (DRUG) News
NASDAQ New 52-Week Highs And Lows
Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting
Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 36.27%: Read This Before Placing a Bet
Bright Minds Biosciences Strengthens Advisory Board With PWS Experts
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)
Press Release: Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)
Bright Minds Biosciences: Strategic Advancements in Serotonergic Therapies and Expansion Into Prader-Willi Syndrome
Bright Minds Biosciences to Present at Key Healthcare Conferences and Grants Equity Incentives
Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH
Bright Minds Biosciences Advances Epilepsy Treatment With BMB-101 Study
'Psychedelics Show Promise As An 'Entirely New Type Of Anti-Inflammatory Treatment,' Research Suggests' - Marijuana Moment
'New York Lawmakers Hold Hearing Psilocybin's Medical Benefits Amid Broader Debate Over Psychedelics Reform' - Marijuana Moment
BTIG Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $72
Bright Minds Biosciences Analyst Ratings
Bright Minds Biosciences' Promising Pipeline and Strategic Expansion Justify Buy Rating
Large Patient Population Is Key Driver For Bright Minds' Growth
Express News | Bright Minds Biosciences Inc : Btig Initiates Coverage With Buy Rating; Target Price $72
BTIG Initiates Bright Minds Biosciences(DRUG.US) With Buy Rating, Announces Target Price $72
Bright Minds Biosciences Initiated at Buy by BTIG
Bright Minds Biosciences Announced Offering
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"